News for Medexus Pharmaceuticals Inc. (MDP.TO)

Revenue: $30 million for fiscal Q3 2025, up from $25.2 million in the same period last year.Adjusted EBITDA: $5.8 million, an increase from $3.2 million in the

Feb 06, 2025 / 01:00PM GMTOperator Good morning, everyone. Welcome to the Medexus Pharmaceuticals third quarter, 2025 conference call. (Operator Instructions) P

Medexus Pharmaceuticals, Inc. (OTCQX:MEDXF) Q3 2025 Earnings Conference Call February 6, 2025 8:00 AM ETCompany ParticipantsVictoria Rutherford - IR,...

**media[526416]**

NOT FOR DISTRIBUTION TO UNITED STATES

Revenue: $26.3 million for fiscal Q2 2025, a decrease from $30.3 million in the same period last year.Adjusted EBITDA: $6 million, an increase from $5.3 millio

Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q2 2025 Earnings Conference Call November 8, 2024 8:00 AM ETCompany ParticipantsVictoria Rutherford - IR,...

Medexus Pharmaceuticals Inc (TSX:MDP) is set to release its Q2 2025 earnings on Nov 7, 2024. The consensus estimate for Q2 2025 revenue is $36.35 million, and t

Aug 08, 2024 / 12:00PM GMTOperator Greetings. Welcome to the Medexus first fiscal quarter 2025 earnings call. (Operator Instructions) Please note this conferenc